← Back to Search

Weight Loss for Peripheral Arterial Disease (Action3 Trial)

N/A

Waitlist Available

Led By Odessa R. Addison, DPT PhD

Research Sponsored by VA Office of Research and Development

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Action3 Trial Summary

This trial will test if weight loss in addition to exercise improves walking ability more than exercise alone in obese older Veterans with peripheral arterial disease.

Eligible Conditions

Peripheral Arterial Disease

Action3 Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Difference in ankle brachial index pre-intervention to post-intervention

Difference in time to onset of calf pain (Claudication Onset Time) pre-intervention to post-intervention

Secondary outcome measures

Change in muscle composition of the calf muscles pre-intervention to post-intervention

Difference in Modified Physical Performance Test scores pre-intervention to post-intervention

Action3 Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Exercise and Weight LossExperimental Treatment2 Interventions

Individuals assigned to this group will be asked to complete both the exercise and weight loss intervention for six months

Group II: ExerciseActive Control1 Intervention

Individuals assigned to this group will be asked to complete the exercise intervention for xic months

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

VA Office of Research and DevelopmentLead Sponsor

1,614 Previous Clinical Trials

3,305,831 Total Patients Enrolled

13 Trials studying Peripheral Arterial Disease

1,440 Patients Enrolled for Peripheral Arterial Disease

Odessa R. Addison, DPT PhDPrincipal InvestigatorBaltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

Odessa R. Addison, PhD DPTPrincipal InvestigatorBaltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD

2 Previous Clinical Trials

100 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there eligibility requirements for participation in this medical trial?

"Those wishing to join this study should be aged between 60 and 80, while also having a diagnosis of peripheral arterial disease. This research project is accepting up to 22 participants at present."

Answered by AI

Is the age limit for this research restricted to those 25 and under?

"This clinical trial is looking to enroll patients who fall within the age bracket of 60 and 80 years old."

Answered by AI

Are there vacancies in this experiment for volunteers?

"According to clinicaltrials.gov, this trial has concluded its recruitment process and is not looking for participants any longer. It was initially posted on October 1st 2015 and last updated June 28th 2022; however, there are a plethora of other studies actively recruiting right now with 439 trials in total."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Exercise and Weight Loss in PAD

2015. "Exercise and Weight Loss in PAD". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02607033.